A Study to Investigate Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type Psoriasis
Status:
Not yet recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
The study is designed to investigate efficacy and safety of KBL697 in patients with Moderate
Plaque Type Psoriasis. KBL697 has been developed as a potential new treatment for Psoriatic
Plaque.